Scott Plesha News Today

JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...

Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 ...

Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned subsidiary of Ligand. Pelthos is committed to commercializing therapeutic products to help patients impacted by diseases with limited treatment options.

(RTTNews) - Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned sub...

BDSI earnings call for the period ending October 31, 2021.

Greetings. Welcome to BioDelivery Sciences First Quarter 2021 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. You may begin. Terry Coelho -- Executive Vice President and Chief Financial Officer Thank you and good morning, everyone. Welcome to our first quarter 2021 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott P...

Operator Greetings, and welcome to the BioDelivery Sciences Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce your host, Ms. Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. Please go ahead. Terry Coelho -- Executive Vice President and Chief Financial Officer Thank you, and good morning, everyone. Welcome t...